| Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S (NCT04430842) | Quadriga Biosciences, Inc. | 2020-07-20 |
| Feasibility of Wearable Activity Trackers for Detection of TOXicity in People Receiving Systemic Anticancer Treatment (NCT04440800) | Royal Marsden NHS Foundation Trust | 2020-07-01 |
| Influence of Local Anesthetic Administration on the Cancer Recurrence Rate After Pancreatic Oncologic Surgery (NCT04449289) | Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian Fodor | 2020-07-01 |
| Pembrolizumab Plus Chemotherapy in 1st Line Treatment of Pancreatic Cancer (NCT04447092) | Seoul National University Hospital | 2020-07-01 |
| High Dose Vitamin C Combined With Metformin in the Treatment of Malignant Tumors (NCT04033107) | Zhongnan Hospital | 2020-07-01 |
| The Therapeutic Evaluation(Both Short-term and Long-term Outcome) of Minimal Invasive Radical Antegrade Modular Pancreatosplenectomy for Left-sided Pancreatic Cancer Patients (NCT03770559) | Peking Union Medical College Hospital | 2020-07-01 |
| Nutrition in Gastrointestinal Tumors (NCT04476082) | University Medicine Greifswald | 2020-06-25 |
| Study on Umorestat Hydrogen Sulfate Capsule in Patients With Locally Advanced/Metastatic Pancreatic Cancer (NCT05329597) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2020-06-24 |
| NaliCap (Irinotecan Liposome (Nal-IRI)/Capecitabine) vs. NAPOLI (Nal-IRI/5-FU/LV) ) in Advanced Pancreatic Cancer (NCT04371224) | Seoul National University Hospital | 2020-06-23 |
| Cost Effectiveness of an Intervention in Hospitalized Patients With Disease-related Malnutrition (NCT04188990) | Hospital Galdakao-Usansolo | 2020-06-15 |
| NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (NCT04332653) | NeoImmuneTech | 2020-06-10 |
| A Study of the Life Changes Experienced by Patients With Pancreatic Cancer (NCT04427761) | Memorial Sloan Kettering Cancer Center | 2020-06-05 |
| The Combination of Camrelizumab and Apatinib as Second-line Therapy for Advanced Pancreatic Carcinoma (NCT04415385) | Zhejiang Cancer Hospital | 2020-06-01 |
| Pooled Mutant KRAS-Targeted Long Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Resected Mismatch Repair Protein (MMR-p) Colorectal and Pancreatic Cancer (NCT04117087) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2020-05-28 |
| A Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid Tumors (NCT04396821) | Suzhou Transcenta Therapeutics Co., Ltd. | 2020-05-28 |
| Effect of Hemp-CBD on Patients With CIPN (NCT04398446) | Main Line Health | 2020-05-27 |
| LY3214996 +/- HCQ in Pancreatic Cancer (NCT04386057) | Kimberly Perez, MD | 2020-05-27 |
| Nivolumab + Ipilimumab + Radiation in MSS Pancreatic Cancer (NCT04361162) | Massachusetts General Hospital | 2020-05-18 |
| A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering (NCT04426669) | Intima Bioscience, Inc. | 2020-05-15 |
| A Randomised Trial of ATRA in a Novel Drug Combination for Pancreatic Cancer (NCT04241276) | Queen Mary University of London | 2020-04-30 |
| Pancreatic Ductal Adenocarcinoma - Microbiome as Predictor of Subtypes (NCT04922515) | University Medical Center Goettingen | 2020-04-25 |
| Ipilimumab, Nivolumab, Tocilizumab and Radiation in Pretreated Patients With Advanced Pancreatic Cancer (NCT04258150) | Herlev Hospital | 2020-04-16 |
| Oncologist-Initiated Cancer Genetic Testing for Pancreatic Cancer Patients (NCT04316507) | Sunnybrook Health Sciences Centre | 2020-04-01 |
| The Italian Version of Cancer Worry Scale (NCT04318756) | Azienda Ospedaliera Universitaria Integrata Verona | 2020-04-01 |
| Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ Cancer (NCT04348643) | Chongqing Precision Biotech Co., Ltd | 2020-02-20 |
| Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas (NCT04275557) | H. Lee Moffitt Cancer Center and Research Institute | 2020-02-18 |
| ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors (NCT04205227) | ENB Therapeutics, Inc | 2020-02-18 |
| Development of a New Immunochemistry Method Using Antibodies of Proteins Related Pancreatic Cancer (NCT04293497) | Gangnam Severance Hospital | 2020-02-17 |
| Neoantigen Peptide Vaccine Strategy in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy (NCT03956056) | Washington University School of Medicine | 2020-02-13 |
| An Extension Study of Methylnaltrexone Bromide (MNTX) in Participants With Advanced Pancreatic Cancer (NCT04151719) | Bausch Health Americas, Inc. | 2020-02-03 |
| Effect of Multi-modal Intervention Care on Cachexia in Patients With Advanced Cancer Compared to Conventional Management (MIRACLE) (NCT04907864) | Kil Yeon Lee | 2020-01-31 |
| A Study of SY 5609, a Selective CDK7 Inhibitor, in Advanced Solid Tumors (NCT04247126) | Syros Pharmaceuticals | 2020-01-23 |
| Evaluation of Complete microscopicE Resection Margin (R0) and Lymph Node Involvement After Standard Pancreatosplenectomy (SPS) Versus Radical Anterograde Modular Pancreatosplenectomy (NCT03679169) | Institut Paoli-Calmettes | 2020-01-17 |
| Pulse-low-dose Rate (PLDR) Radiation in Pancreatic Cancer (NCT04452357) | Fox Chase Cancer Center | 2020-01-13 |
| A Study of Methylnaltrexone Bromide (MNTX) in Participants With Advanced Pancreatic Cancer (NCT04083651) | Bausch Health Americas, Inc. | 2020-01-06 |
| Metronomic Chemotherapy With Capecitabine for Pancreatic Cancer (NCT03959150) | Ruijin Hospital | 2020-01-05 |
| Pancreaticoduodenectomy: Outcomes of a Complex Surgical Procedure From a Developing Country (NCT04395898) | Shaukat Khanum Memorial Cancer Hospital & Research Centre | 2020-01-01 |
| Surgery for Pancreatic Cancer With Oligo-Metastasis (NCT04196816) | University Hospital, Montpellier | 2020-01-01 |
| The Comparison of Miniinvasive and Open Pancreaticoduodenectomy for Cancer Pancreaticobiliary Zone (NCT04763642) | State Budget Public Health Institution Scientific Research Institute - Ochapovsky Regional Clinical Hospital | 2020-01-01 |
| Microbiome Analysis in esoPhageal, PancreatIc and Colorectal CaNcer Patients Undergoing Gastrointestinal Surgery (NCT04189393) | Radboud University Medical Center | 2020-01-01 |
| Glucose Monitoring to Predict and Treat High Glucose Levels After Steroid Treatment (NCT04210128) | Memorial Sloan Kettering Cancer Center | 2019-12-20 |
| A Study of Live Biotherapeutic Product MRx0518 With Hypofractionated Radiation Therapy in Resectable Pancreatic Cancer (NCT04193904) | 4D pharma plc | 2019-12-20 |
| OPTimizing Treatment Focused Genetic Testing IN Cancer (NCT04066361) | Dana-Farber Cancer Institute | 2019-12-19 |
| Study of Personalized Tumor Vaccines (PCVs) and a PD-L1 Blocker in Patients With Pancreatic Cancer That Can be Treated With Surgery (NCT04161755) | Memorial Sloan Kettering Cancer Center | 2019-12-13 |
| Focused Ultrasound for the Treatment of Pancreatic Cancer - an International Registry (NCT03724435) | Focused Ultrasound Foundation | 2019-12-06 |
| Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers (NCT03935893) | Udai Kammula | 2019-12-03 |
| Pancreatic Cancer and Carbon Ion Radiotherapy (NCT04194268) | University Hospital Heidelberg | 2019-12-03 |
| Training Endoscopists to Perform On-site Rapid Cytological Evaluation for EUS-FNA of Solid Pancreatic Lesions (NCT04509687) | Changhai Hospital | 2019-12-01 |
| Applying PET/MR in Oncology - a Prospective Project (NCT04158414) | Tel-Aviv Sourasky Medical Center | 2019-11-28 |
| Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers (NCT03801915) | National Cancer Institute (NCI) | 2019-11-13 |
| Gemcitabine and Z650 in Treating Patients With Metastatic or Recurrent Pancreatic Cancer (NCT04131192) | Sunshine Lake Pharma Co., Ltd. | 2019-11-11 |
| The Safety and Efficacy of the Combination of Raltitrexed for Injection and Nab-Paclitaxel in Advanced Pancreatic Cancer (NCT04581876) | Fudan University | 2019-11-01 |
| The Accurateness of Endoscopic Ultrasound Elastography in the Guidance of EUS-FNA in Solid Pancreatic Lesions (NCT04148755) | Assiut University | 2019-10-29 |
| The Mechanism of Enhancing the Anti-tumor Effects of CAR-T on PC by Gut Microbiota Regulation (NCT04203459) | First Affiliated Hospital of Harbin Medical University | 2019-10-20 |
| A Study of Armed, Activated T-Cells in Patients With Advanced Pancreatic Cancer (NCT04137536) | Memorial Sloan Kettering Cancer Center | 2019-10-17 |
| Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy (NCT04068896) | NGM Biopharmaceuticals, Inc | 2019-10-16 |
| A Pilot Study of BXCL701 in Patients With Pancreatic Cancer (NCT04123574) | BioXcel Therapeutics Inc | 2019-10-15 |
| A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors (NCT03997968) | Cyteir Therapeutics, Inc. | 2019-10-09 |
| The Occurence of Pancreatic Cancer Studied in Association With Newly Diagnosed Diabetes in the Elderly (NCT04164602) | University of Pecs | 2019-10-09 |
| UCSF PANC Cyst Registry (NCT04291651) | University of California, San Francisco | 2019-10-08 |
| MFOLFIRINOX And Stereotactic Radiotherapy (SBRT) for Pancreatic Cancer With High Risk and Locally Advanced Disease (NCT04089150) | Australasian Gastro-Intestinal Trials Group | 2019-10-01 |
| Phase II Study to Evaluate Modified Folfirinox and Stereotactic Body Radiation Therapy in Non-metastatic Unresectable Pancreatic Adenocarcinoma (NCT03991962) | Yale University | 2019-09-24 |
| Early Palliative Care in Pancreatic Cancer - a Quasi-experimental Study (NCT04290364) | Inge Høgh Dufva | 2019-09-21 |
| Ex-vivo Ultrasound Guided Radiofrequency Ablation on Pancreatic Solid Lesions (NCT06371716) | IRCCS San Raffaele | 2019-09-12 |
| Study of Lonsurf in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Advanced (PDAC) (NCT04046887) | Patrick Joseph Loehrer Sr. | 2019-09-11 |
| Perioperative Epidural Block and Dexamethasone in Pancreatic Cancer Surgery (NCT04025840) | Peking University First Hospital | 2019-09-11 |
| mFOLFIRINOX as Adjuvent Chemotherapy in Treating Chinese Pancreatic Cancer Patients (NCT04084496) | Sun Yat-sen University | 2019-09-01 |
| Whipple Protein Study (NCT04306874) | Thomas Jefferson University | 2019-08-20 |
| Nasobiliary Drain Assisted EUS-guided Gastroenterostomies in Unresectable Malignant Gastric Outlet Obstruction (NCT04660695) | Hospital del Rio Hortega | 2019-08-15 |
| Glycocalyx Levels in Patients Undergoing Pancreatectomy (NCT04058236) | University of Malaya | 2019-08-15 |
| Study of Gemcitabine Plus Nab-paclitaxel Versus S1 Plus Nab-paclitaxel in Metastatic Adenocarcinoma of the Pancreas (NCT03779464) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2019-08-01 |
| A Study of a Personalized Cancer Vaccine Targeting Shared Neoantigens (NCT03953235) | Gritstone bio, Inc. | 2019-07-18 |
| Development of Biomarker for the Evaluation of Response After Neoadjuvant Therapy in Patients With Pancreatic Cancer (NCT04110769) | Asan Medical Center | 2019-07-17 |
| A Phase II Study of S-1 Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer in Taiwan (NCT04070313) | TTY Biopharm | 2019-07-11 |
| Liposomal Irinotecan Plus 5-FU / LV Combined With Paricalcitol in Patients With Advanced Pancreatic Cancer Progressed on Gemcitabine-based Therapy (NCT03883919) | Washington University School of Medicine | 2019-07-11 |
| Efficacy of Fistulotomy for Biliary Cannulation (NCT04037007) | Coordinación de Investigación en Salud, Mexico | 2019-07-03 |
| Evaluation of NETs in Patients With Solid Cancers Associated With a High Risk of Venous Thromboembolic Events (NCT04294589) | Assistance Publique - Hôpitaux de Paris | 2019-07-01 |
| Study of Neoadjuvent Chemotherapy Followed by SBRT in Patients With Resectable and Borderline Resectable Pancreatic Cancer (NCT04130399) | Indiana University | 2019-07-01 |
| EXplanted LIver and Ex-vivo Pancreatic Specimen Evaluation by 7 TESLA MRI (NCT04012021) | University of Pisa | 2019-05-24 |
| Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients (NCT03745326) | National Cancer Institute (NCI) | 2019-05-16 |
| A Study of CCT301-59 CAR T Therapy in Adult Subjects With Recurrent or Refractory Solid Tumors (NCT03960060) | Shanghai PerHum Therapeutics Co., Ltd. | 2019-05-16 |
| Predicting Disease Progression and/or Recurrence in Cancer (NCT04776837) | Massachusetts General Hospital | 2019-05-15 |
| Biological Effect of Warfarin on Pancreatic Cancer (NCT03536208) | University of Texas Southwestern Medical Center | 2019-05-15 |
| Prospective Monocentric Clinical-biological Database (NCT04136132) | Institut du Cancer de Montpellier - Val d'Aurelle | 2019-05-15 |
| High Dose Ascorbic Acid and Nanoparticle Paclitaxel Protein Bound and Cisplatin and Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer (NCT03908333) | Medical College of Wisconsin | 2019-05-01 |
| Clinical Research of ROBO1 Specific BiCAR-NK Cells on Patients With Pancreatic Cancer (NCT03941457) | Asclepius Technology Company Group (Suzhou) Co., Ltd. | 2019-05-01 |
| Second-line Study of PEGPH20 and Pembro for HA High Metastatic PDAC (NCT03634332) | Pancreatic Cancer Research Team | 2019-05-01 |
| Study With Andes-1537 in Patients With Specific Types of Advanced Solid Tumor (NCT03985072) | Andes Biotechnologies | 2019-04-26 |
| A Longitudinal, Observational Biomarker Study in Pancreatic Cancer Patients Receiving Chemotherapy (NCT04281511) | National Cancer Center, Korea | 2019-04-03 |
| Monitoring of patIents With Microdialysis Following Pancreaticoduodenectomy (NCT03631173) | Oslo University Hospital | 2019-04-02 |
| Borderline Resectable Pancreatic Cancer Neoadjuvant Chemoradiotherapy Clinicaltrial-1 (NCT03777462) | Changhai Hospital | 2019-04-01 |
| Peptide-based Immunization for Colon- and and Pancreas-carcinoma (NCT03871790) | CENTOGENE GmbH Rostock | 2019-04-01 |
| Combination of Anti-PD-1 Antibody and Chemotherapy in Pancreatic Cancer (NCT03983057) | Zhejiang University | 2019-04-01 |
| Iodine-125 Seed Implantation Therapy for Locally Advanced Pancreatic Cancer (NCT03882866) | Ruijin Hospital | 2019-03-28 |
| Combination of Anti-PD-1 Antibody and Chemotherapy in Metastatic Pancreatic Cancer (NCT03977272) | Zhejiang University | 2019-03-27 |
| TPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced Cancers (NCT03829436) | Tempest Therapeutics | 2019-03-20 |
| A Study of NBF-006 in Non-Small Cell Lung, Pancreatic, or Colorectal Cancer (NCT03819387) | Nitto BioPharma, Inc. | 2019-03-18 |
| Pancreatic Cancer Malnutrition and Pancreatic Exocrine Insufficiency in the Course of Chemotherapy in Unresectable Pancreatic Cancer (NCT04112836) | Moscow Clinical Scientific Center | 2019-03-15 |
| A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer (NCT03816163) | Astellas Pharma Global Development, Inc. | 2019-03-15 |
| Florida Pancreas Collaborative Next Generation Biobank (NCT03851133) | H. Lee Moffitt Cancer Center and Research Institute | 2019-03-04 |